Israeli Delegation of Medical Device Firms Seeks Opportunities in Indian Market
Published By : 03 Jul 2015 | Published By : QYRESEARCH
An Israeli delegation of leading medical device companies is meeting Indian health care distributors, providers, and importers in Delhi and Mumbai to explore the possibilities of working with them.
The Israeli delegation conducted business to business meetings with Hinduja Hospital and Kokilaben Dhirubhai Ambani Hospital in Mumbai and Rockland, Fortis, Max, Medanta, and Artimis hospitals in Delhi.
Daniel Carmon, Israeli ambassador to India commented on the development and told the press that he is certain that Israeli medical device technologies can and will have a positive and strong impact in India. He expressed his affirmation that this will also strengthen the partnership between India and Israel.
The medical devices companies that form a part of the Israeli delegation include LevEI Diagnostics, Insightec, MCS, Maabarot, Trig Medical, Persys Medical, and Tuttanuer.
Yoni Ben Zaken, Israel’s Commercial Attache said that several Israeli firms have shown keen interest in being a part of the rapidly growing health care system in India, which is determined to provide the best medical services and procedures to the Indian public. Yoni Ben Zaken further stated that he believed there was no doubt that this partnership between India and Israel will prove to be beneficial to both the countries.
The Israeli delegation of medical devices companies are focusing on segments such as cardiovascular and peripheral vascular, diabetes, oncology, gynecology and women health, intensive care, neurosurgery, EMR, orthopedic, obstetrics, and wound management.
The medical device sector in Israel is also presently undergoing major developments with an increasing number of investments and start ups making the rounds.
A joint venture between Philips and Teva Pharmaceutical Industries was announced on Wednesday. The two companies are investing up to US$ 26.5 million in Samara Ventures, the joint venture, and aims to invest in health technology and medical device start ups in Israel over a course of eight years.